BHST Stock Overview
Operates as a biotechnology company. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
BioHarvest Sciences Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$6.22 |
| 52 Week High | CA$7.70 |
| 52 Week Low | CA$0.0011 |
| Beta | 1.49 |
| 11 Month Change | 29.58% |
| 3 Month Change | 13.71% |
| 1 Year Change | 51.89% |
| 33 Year Change | -39.88% |
| 5 Year Change | n/a |
| Change since IPO | -29.34% |
Recent News & Updates
Recent updates
Shareholder Returns
| BHST | US Personal Products | US Market | |
|---|---|---|---|
| 7D | 3.7% | 4.2% | 2.2% |
| 1Y | 51.9% | -11.6% | 31.7% |
Return vs Industry: BHST exceeded the US Personal Products industry which returned -12.5% over the past year.
Return vs Market: BHST exceeded the US Market which returned 31.1% over the past year.
Price Volatility
| BHST volatility | |
|---|---|
| BHST Average Weekly Movement | 8.5% |
| Personal Products Industry Average Movement | 8.4% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: BHST has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: BHST's weekly volatility has decreased from 79045% to 9% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Ilan Sobel | www.bioharvest.com |
BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells.
BioHarvest Sciences Inc. Fundamentals Summary
| BHST fundamental statistics | |
|---|---|
| Market cap | US$106.61m |
| Earnings (TTM) | -US$16.23m |
| Revenue (TTM) | US$19.13m |
5.6x
P/S Ratio-6.6x
P/E RatioIs BHST overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BHST income statement (TTM) | |
|---|---|
| Revenue | US$19.13m |
| Cost of Revenue | US$9.29m |
| Gross Profit | US$9.84m |
| Other Expenses | US$26.07m |
| Earnings | -US$16.23m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 25, 2024
| Earnings per share (EPS) | -0.94 |
| Gross Margin | 51.44% |
| Net Profit Margin | -84.84% |
| Debt/Equity Ratio | 17.4% |
How did BHST perform over the long term?
See historical performance and comparison